Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_assertion type Assertion NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_head.
- NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_assertion description "[COX-2 has also been strongly implicated in urinary bladder cancer primarily by studies with nonselective COX- and COX-2-selective inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_provenance.
- NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_assertion evidence source_evidence_literature NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_provenance.
- NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_assertion SIO_000772 15753378 NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_provenance.
- NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_assertion wasDerivedFrom befree-2016 NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_provenance.
- NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_assertion wasGeneratedBy ECO_0000203 NP484315.RA_HCGkktZyh7tC8JyhyjFsF2fPAV99PKsngehhgR0lU4130_provenance.